Prashanth Puspanathan
Alfred Hospital
6 Papers
21 Citations
Prashanth Puspanathan is an academic researcher from Alfred Hospital. The author has contributed to research in topics: Hallucinogen & Stigma (botany). The author has an hindex of 2, co-authored 4 publications. Previous affiliations of Prashanth Puspanathan include World Psychiatric Association.
Chat about Author
Papers
Associations of early career psychiatrists worldwide: history, role, and future perspectives
Andrea Fiorillo,Mariana Pinto da Costa,Takashi Nakamae,Prashanth Puspanathan,Florian Riese,Felipe Almeida Picon,Hussien Elkholy +6 more
TL;DR: An overview of the aims, structure, and organization of some of the most important international associations of early career psychiatrists (ECPs) is provided.
21
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy
TL;DR: In this paper , the authors suggest that the potential application of VR in modulating psychedelic-assisted psychotherapy demands further exploration and an evidence-based approach to both design and implementation.
18
The Future of Psychiatry: Early Career Psychiatrists
Felipe Almeida Picon,Felipe Almeida Picon,Hussien Elkholy,Hussien Elkholy,Mariana Pinto da Costa,Mariana Pinto da Costa,Mariana Pinto da Costa,Prashanth Puspanathan,Prashanth Puspanathan,Takashi Nakamae,Takashi Nakamae,Florian Riese,Florian Riese +12 more
- 01 Jan 2019
TL;DR: The goal of this chapter is to briefly state the many possible areas of action for early career psychiatrists, to increase awareness of their current importance, and to stress their crucial role in the future of psychiatry.
4
Editorial training models for early-career psychiatrists
Rajiv Radhakrishnan,Rajiv Radhakrishnan,Tobias Wasser,Felipe Almeida Picon,Felipe Almeida Picon,Prashanth Puspanathan,Prashanth Puspanathan,Mariana Pinto da Costa,Mariana Pinto da Costa,Mariana Pinto da Costa,Takashi Nakamae,Takashi Nakamae,Hussien Elkholy,Hussien Elkholy +13 more
2
Psychedelic research in Australia: Breaking through the stigma.
TL;DR: While mood stabilizers add cognition, activity and functioning, they leave out many of the problems which the authors' patients face—suboptimal resiliency to stress, a tendency to become anxious and to ruminate on good and bad thoughts, irritability, mood lability, as well as subtle psychotic thoughts.